Point72 Hong Kong’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-28,019
| Closed | -$116K | – | 1842 |
|
2022
Q2 | $116K | Buy |
28,019
+25,648
| +1,082% | +$106K | ﹤0.01% | 709 |
|
2022
Q1 | $14K | Sell |
2,371
-3,699
| -61% | -$21.8K | ﹤0.01% | 1077 |
|
2021
Q4 | $46K | Buy |
+6,070
| New | +$46K | ﹤0.01% | 821 |
|
2021
Q3 | – | Sell |
-11,715
| Closed | -$140K | – | 1780 |
|
2021
Q2 | $140K | Buy |
11,715
+11,418
| +3,844% | +$136K | ﹤0.01% | 683 |
|
2021
Q1 | $4K | Sell |
297
-2,692
| -90% | -$36.3K | ﹤0.01% | 1161 |
|
2020
Q4 | $47K | Buy |
+2,989
| New | +$47K | ﹤0.01% | 776 |
|
2019
Q2 | – | Sell |
-157
| Closed | -$1K | – | 1371 |
|
2019
Q1 | $1K | Buy |
157
+79
| +101% | +$503 | ﹤0.01% | 956 |
|
2018
Q4 | $1K | Buy |
+78
| New | +$1K | ﹤0.01% | 812 |
|
2018
Q2 | – | Sell |
-622
| Closed | -$12K | – | 1147 |
|
2018
Q1 | $12K | Buy |
+622
| New | +$12K | 0.01% | 682 |
|
2017
Q4 | – | Sell |
-71
| Closed | -$1K | – | 1064 |
|
2017
Q3 | $1K | Sell |
71
-871
| -92% | -$12.3K | ﹤0.01% | 727 |
|
2017
Q2 | $8K | Buy |
+942
| New | +$8K | 0.01% | 504 |
|